Reborn Coffee, Inc. (REBN) stock: key figures, P/E, revenue and dividend
Consumer Discretionary · United States · ISIN US75618M3051
Reborn Coffee, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 8.09 m USD |
| Gross profit | 7.44 m USD |
| Operating income | -5.79 m USD |
| EBIT | -8.74 m USD |
| Net income | -9.14 m USD |
| Diluted EPS – continuing operations | -1.73 USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Reborn Coffee, Inc.
Reborn Coffee, Inc., through its subsidiaries, operates and franchises retail locations, kiosks, and cafes that focus on serving specialty-roasted coffee in North America and Asia. It purchases, roasts, and sells coffee, tea and other beverages, and various food items. It offers products in various form factors, such as whole bean roasted coffee bags, single-serve drip bags, pour over packs, and cold brew concentrates. The company also offers its products online. Reborn Coffee, Inc. was founded in 2014 and is headquartered in Brea, California.
More stocks
- Moleculin Biotech, Inc. (MBRX)
- Upland Software, Inc. (UPLD)
- CalciMedica, Inc. (CALC)
- Vistagen Therapeutics, Inc. (VTGN)
- Summit Networks Inc. (SNTW)
- INTRUSION INC (INTZ)
- Cardlytics, Inc. (CDLX)
- VPR Brands, LP. (VPRB)
- Ensysce Biosciences, Inc. (ENSC)
- Crown Equity Holdings, Inc. (CRWE)
- Rocket One Inc. (RKTO)
- Adaptimmune Therapeutics PLC (ADAPY)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.